157 related articles for article (PubMed ID: 20195904)
1. Phospholipase and esterase production by clinical strains of Fonsecaea pedrosoi and their interactions with epithelial cells.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
Mycopathologia; 2010 Jul; 170(1):31-7. PubMed ID: 20195904
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of extracellular enzymes from chromoblastomycosis agents reveals the potential association of phospholipase with the severity of the lesions.
Montoya AM; Montesino CA; Carrión-Álvarez D; González GM; Rojas OC
Microb Pathog; 2020 Oct; 147():104367. PubMed ID: 32649963
[TBL] [Abstract][Full Text] [Related]
3. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.
Santos AL; Palmeira VF; Rozental S; Kneipp LF; Nimrichter L; Alviano DS; Rodrigues ML; Alviano CS
FEMS Microbiol Rev; 2007 Sep; 31(5):570-91. PubMed ID: 17645522
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
Fransisca C; He Y; Chen Z; Liu H; Xi L
Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
[TBL] [Abstract][Full Text] [Related]
5. Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.
Dong B; Tong Z; Li R; Chen SC; Liu W; Liu W; Chen Y; Zhang X; Duan Y; Li D; Chen L
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006237. PubMed ID: 29481557
[TBL] [Abstract][Full Text] [Related]
6. The major chromoblastomycosis fungal pathogen, Fonsecaea pedrosoi, extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key's host structures.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):21-9. PubMed ID: 16420593
[TBL] [Abstract][Full Text] [Related]
7. Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.
Najafzadeh MJ; Sun J; Vicente V; Xi L; van den Ende AH; de Hoog GS
Med Mycol; 2010 Sep; 48(6):800-6. PubMed ID: 20302550
[TBL] [Abstract][Full Text] [Related]
8. [Erythematous type scaly papule on the abdomen: chromoblastomycosis due to Fonsecaea pedrosoi].
El Euch D; Mokni M; Haouet S; Trojjet S; Zitouna M; Ben Osman A
Med Trop (Mars); 2010 Feb; 70(1):81-3. PubMed ID: 20337123
[TBL] [Abstract][Full Text] [Related]
9. Fonsecaea pedrosoi as a rare cause of acute conjunctival ulceration.
Adibelli FM; Karabicak N; Akal A; Goncu T; Yilmaz OF; Bayraktar M
Arq Bras Oftalmol; 2016; 79(4):261-3. PubMed ID: 27626154
[TBL] [Abstract][Full Text] [Related]
10. Lipolytic activity of chromoblastomycosis agents measured by infrared spectroscopy and chemometric methods.
Corbellini VA; Scroferneker ML; Carissimi M; da Costa JM; Ferrão MF
Med Mycol; 2009 Feb; 47(1):63-9. PubMed ID: 19101839
[TBL] [Abstract][Full Text] [Related]
11. Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis.
Salgado CG; da Silva JP; Diniz JA; da Silva MB; da Costa PF; Teixeira C; Salgado UI
Rev Inst Med Trop Sao Paulo; 2004; 46(1):33-6. PubMed ID: 15057332
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence.
Palmeira VF; Kneipp LF; Rozental S; Alviano CS; Santos AL
PLoS One; 2008; 3(10):e3382. PubMed ID: 18852883
[TBL] [Abstract][Full Text] [Related]
13. Ectophosphatase activity in conidial forms of Fonsecaea pedrosoi is modulated by exogenous phosphate and influences fungal adhesion to mammalian cells.
Kneipp LF; Rodrigues ML; Holandino C; Esteves FF; Souto-Padrón T; Alviano CS; Travassos LR; Meyer-Fernandes JR
Microbiology (Reading); 2004 Oct; 150(Pt 10):3355-62. PubMed ID: 15470114
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase activity on the cell wall of Fonsecaea pedrosoi.
Kneipp LF; Palmeira VF; Pinheiro AA; Alviano CS; Rozental S; Travassos LR; Meyer-Fernandes JR
Med Mycol; 2003 Dec; 41(6):469-77. PubMed ID: 14725320
[TBL] [Abstract][Full Text] [Related]
15. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.
Alviano DS; Franzen AJ; Travassos LR; Holandino C; Rozental S; Ejzemberg R; Alviano CS; Rodrigues ML
Infect Immun; 2004 Jan; 72(1):229-37. PubMed ID: 14688100
[TBL] [Abstract][Full Text] [Related]
16. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
[TBL] [Abstract][Full Text] [Related]
18. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Yang YP; Li W; Huang WM; Zhou Y; Fan YM
Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
[TBL] [Abstract][Full Text] [Related]
19. Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle.
Khan S; Kumar A; Vinod V; Prabhakar V; Eapen M; Thomas J; Dinesh K; Karim S
J Infect Dev Ctries; 2015 Mar; 9(3):325-9. PubMed ID: 25771474
[TBL] [Abstract][Full Text] [Related]
20. Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
Res Microbiol; 2006 Nov; 157(9):819-26. PubMed ID: 16959473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
